Company / Depreciation & Amortization
LivaNova Depreciation & Amortization History
FY2016-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$29.0M
FY2022
5-year range
$29.0M / $30.3M
FY2018-FY2022
Trend
-4.2%
vs FY2021
Sector context
#92 of 141
Health Care
What the data says
At $29M, LivaNova's depreciation & amortization ranks #50 of 141 in the Health Care sector. Improved from $85M to $29M over the past 6 years.
Based on SEC 10-K filings.
$29M in FY2022.
Improved from $85M to $29M over the past 6 years.
Health Care sector context is included.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#50 of 141 in Health CareTop 35% of 141This company $29.0M Sector average $344.6M
▼
-91.6% below sector average
Key checks
Key Insights
- In FY2022, depreciation & amortization decreased 4.2% year-over-year.
- Ranks #92 out of 141 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 0.84 (distress zone, below 1.8 threshold)
- Negative profit margin: -16.1%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | $29.0M | -4.2% |
| FY2021 | $30.3M | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | $85.4M | +692.9% |
As of FY2022 · SEC 10-K · Updated Jun 30, 2026